First-in-Human Safety, PK, and Food Effect Study of Single Ascending Doses of G1T38 in Healthy Volunteers
NCT02821624
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
76
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
DRUG:
G1T38 (CDK 4/6 Inhibitor)
DRUG:
Placebo
Sponsor
G1 Therapeutics, Inc.